The role of TXNDC5 in castration-resistant prostate cancer—involvement of androgen receptor signaling pathway
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/onc2014401.pdf
Reference40 articles.
1. Zhao L, Yu N, Guo T, Hou Y, Zeng Z, Yang X et al. Tissue biomarkers for prognosis of prostate cancer: A systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2014; 23: 1047–1054.
2. Baumann C, Behbahani TE . EAU guidelines for prostate cancer: to screen or not to screen? Actas Urol Esp 2012; 36: 1.
3. Scher HI, Sawyers CL . Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. J Clin Oncol 2005; 23: 8253–8261.
4. Sharifi N . Mechanisms of androgen receptor activation in castration-resistant prostate cancer. Endocrinology 2013; 154: 4010–4017.
5. Egan A, Dong Y, Zhang H, Qi Y, Balk SP, Sartor O . Castration-resistant prostate cancer: adaptive responses in the androgen axis. Cancer Treat Rev 2014; 40: 426–433.
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Parecoxib Enhances Resveratrol against Human Colorectal Cancer Cells through Akt and TXNDC5 Inhibition and MAPK Regulation;Nutrients;2024-09-06
2. Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glance;Frontiers in Endocrinology;2024-06-03
3. Thioredoxin Domain Containing 5 (TXNDC5): Friend or Foe?;Current Issues in Molecular Biology;2024-04-04
4. The role and mechanism of TXNDC5 in disease progression;Frontiers in Immunology;2024-04-02
5. Endoplasmic Reticulum Protein TXNDC5 Interacts with PRDX6 and HSPA9 to Regulate Glutathione Metabolism and Lipid Peroxidation in the Hepatic AML12 Cell Line;International Journal of Molecular Sciences;2023-12-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3